HIV-1 infection has increased among women in recent years. The HIV-1 env gene (structural gene) has the greatest variation in all the HIV gene regions. In this study, 58 samples from infants infected with HIV-1 via perinatal transmission were analyzed. All the 58 samples were submitted to Nested-polymerase chain reaction of the env gene region for posterior viral genotyping using EN 70 and EN 85 (first polymerase chain reaction) and EN 80 and EN 95 (second polymerase chain reaction) primers, with the product of the 682 base pair amplification. After Nested-polymerase chain reaction for genotyping, purification of the product, and direct sequencing in a MegaBace 1000 automatic sequencer, 56 genotypes were found in the 58 HIV-1-positive children of the study, where 47 (83.93%) were HIV-1 subtype B infected and 9 (16.07%) were HIV-1 subtype F1 infected. The results demonstrate the predominance of subtype B followed by subtype F in Southeast Brazil.
Introduction
The perinatal transmission of the HIV-1 is the main form of infection in pediatrics, corresponding to 90% of transmission in Brazil among children aged 13 years and under. The risk of vertical transmission of HIV from the HIV-infected mothers to infants varies from 15% to 40%. This transmission can occur because of transplacentary form, canal of the childbirth, or breast-feeding after the childbirth. 1 HIV-1 infection has increased particularly among women, most of whom are of childbearing age. 2, 3 The HIV-1 virus presents genetic DNA of nearly 10 kilobase (kb). 4 The region of the envelope (env) gene of the 120 (gp120) glycoprotein of the HIV-1 is capable of a wide variation and originates different HIV-1 genotypes. 5 HIV is characterized by a high degree of genetic variation and recombination. Based on phylogenetic analysis of env sequences, HIV type 1 (HIV-1) strains have been divided into 3 major groups: the M, or Main, group; the O, or Outlier, group 6 ; and the recently described N group (non-M, non-O). 6 The M group is further divided into 9 ''pure'' subtypes (subtypes A to D, F to H, J, and K). [7] [8] [9] Recombination between these subtypes has led to the generation of many circulating recombinant forms (CRF). Already 15 different CRFs have been identified and may play a major role in local epidemics. 10 The O group viruses have a few variations and their distribution is limited, being found more frequently in Central and Western Africa. 11 Several studies on the molecular epidemiology of HIV-1 in Brazil have shown predominance of subtype B, with the presence of additional subtypes such as F and C. [12] [13] [14] Currently, there are several methods for the determination of the HIV-1 subtypes; among the polymerase chain reaction (PCR)-based methods used to define the subtypes, one of the most used techniques is heteroduplex mobility assay (HMA). 15 There are also techniques that are based on serum analyses (V-3 ELISA). 6, 11 Direct sequencing of genetic fragments is often used as the gold standard test for the determination of the HIV-1 subtypes. 16 This test consists of sequencing DNA fragments to be studied so that it is possible to analyze the genetic variations in HIV. 11 The characterization of virus strains globally by the partial or total sequencing of the genome can offer a consistent structure to outline virus variation. The generation of such sequences is a crucial component in global diversity surveillance studies. 16 HIV-1 genetic variations may have significant implications in the clinical retroviral evolution of AIDS and in the development of an effective vaccine against the HIV-1 virus. 17 The purpose of this study was to determine the HIV-1 subtypes from perinatally infected children, in the metropolitan region of Campinas (SP), Brazil.
Materials and Methods

Patients
This study included 58 HIV-1-positive children who were infected perinatally most of whom were followed at the Hospital das Clínicas da Universidade Estadual de Campinas (UNICAMP). The positive samples selected for this study were collected during 1999 to 2003. Informed consent was obtained from all patients and the protocol was approved by the Hospital's Ethics Committee.
Blood Samples
Peripheral blood, 3 to 5 mL, was collected via venous puncture into a sterile test tube containing ethylenediaminetetraacetic acid (EDTA).
DNA Extraction
Initially, plasma was eliminated by centrifugation at 698.125g for 20 minutes; the red blood cells were then treated with 0.0114 mol/L NH 4 Cl (fivefold cell volume), and 0.01 mol/L NH 4 HCO 3 (0.5-fold cell volume). The leukocytes went through 2 washing stages, first with 10 mmol/L Tris-HCl (pH ¼ 7.6); 10 mmol/L KCl; 10 mmol/L MgCl 2 and 20 mmol/L EDTA; and 50 mL of Nonidet p40. The second wash was carried out using 0.8 mL of a solution containing 10 mmol/L Tris-HCl (pH ¼ 7.6); 10 mmol/L KCl; 0.4 mol/L NaCl; MgCl 2 10 mmol/L and 2 mmol/L EDTA; and 0.025 mL of 20% duodecil sodium sulfate (SDS), during this stage cells were incubated for 40 minutes at a temperature of 56 C. After incubation, 0.3 mL of 5 mol/L NaCl was added, only the supernatant was used. The DNA was precipitated by the addition of 4 mL of iced absolute ethanol and solubilized in distilled, deionized, and sterile water, was then incubated for 8 hours at 37 C, and was subsequently evaluated in a spectrophotometer at an optical density of 260 nm.
PCR of DNA Proviral Fragment of HIV-1 Env Gene
The PCR of the DNA proviral fragment of the HIV-1 env gene (gp120, region C2 to V3) was performed in 2 stages; first with pairs of outer primers and second with inner primers, in eppendorf tubes (0.6 mL capacity), with a total volume of 20 mL amplification mix. The mixture for each reaction contained 0.4 mL DNA, 50 mmol/L KCl; 10 mmol/L Tris-HCl (pH ¼ 8.4); 2.5 mmol/L MgCl 2 ; 0.1 mmol/L of primer (EN70-EN85), 200 mmol/L deoxyribonucleic mixture-dNTPs (dATP, dGTP, dCTP, dTTP; GIBCO-BRL); 2.0 U of Taq DNA polymerase (GIBCO-BRL); and 30 mL of mineral oil (Sigma). The target DNA was amplified using a ''Cetus'' Perkin-Elmer 9600 thermal cycler (Perkin-Elmer Cetus, Norwalk, Conn). The reaction was initially performed for 1 cycle at 94 C for 5 minutes, and after that for 30 cycles of amplification, each cycle having the following conditions: 94 C for 30 seconds; 57 C for 1 minute; 75 C for 30 seconds, these 30 cycles were followed by a single cycle at 75 C for 5 minutes. From the first PCR (performed with outer primer to viral region), 0.4 mL of the product was then transferred into a second test tube containing 19.6 mL of the same reaction medium described in the first reaction of the amplification, but with the pair of inner primers used in the initial PCR (EN80-EN95), also followed by the same program of amplification. As a positive control for the reaction, symptomatic patients known to be HIV-1 infected were used and as a negative control, patients proven not to be HIV-1 infected were used as well as the blank part of the reaction (water). The product of the second PCR (8 mL) was analyzed in 2.0% agarose gel electrophoresis stained with ethidium bromide.
The samples were also analyzed in 2.0% agarose gel using the Low Mass Marker at the step before the purification of the PCR product.
Purification of the PCR Product
The Qiagen kit was used for the purification of the PCR product (682 base pair [bp]).
DNA Sequencing
The samples were directly sequenced in a MegaBace 1000 R automatic sequencer, using the dideoxynucleotide terminator method. For this procedure, each termination molecule is marked with fluorescein as a donor group and with a hodamine acceptor (hodamine 110, hodamina-6-G, tetramethyl hodamine e hodamine X).
The reaction conditions for sequencing were primer (5 mmol/L), ET reagent terminator (4 mL), and 2.0 mL of the product of the Nested-PCR, and added distilled water to complete a volume of 15 mL. Afterward 35 cycles were carried out with the following conditions: 95 C for 20 seconds, 58 C for 15 seconds, 60 C for 1 minute.
The marked and nonincorporated dideoxynucleotides were removed via their precipitation with 50 mL of absolute ethanol and 2 mL of acetate of 7.5 mol/L ammonium and centrifuged at 4000 rpm at 4 C. The precipitant was washed with 70% ethanol (100 mL), dried and resuspended with 10 mL of 70% formamid solution (1 mmol/L EDTA). Finally, a denaturation was carried out for 3 minutes at 65 C and a plate was inserted in the MegaBace System. The data were analyzed by the Cimaron 1.43 software after the end of the sequencing.
The results obtained by the automatic sequencer were interpreted through the comparative analysis (alignment) of the sequences obtained by the chromatography (coupled with the automatic sequencer), with the writings at the Genomic Library at the Gen Bank, in www.ncbi.nlm.nih.gov-Retrovirus resource-Genotyping tools-HIV type I (HIV-1), to obtain the HIV-1 subtype.
Results
The nested-PCR for the posterior sequencing and genotyping of HIV-1 was standardized and applied in 58 patients (followed at the UNICAMP) included in this study. The nested-PCR presented an appropriate result (amplification of a 682-bp product; Figure 1 ), 18 allowing the viral sequencing and posterior viral genotyping in 56 patients. A nested-PCR of good quality was not achieved in 2 patients; for this reason it was not possible to carry out sequencing with an appropriate result and thus a conclusion of the viral subtype. Some of the problems involved in this study result from the nonamplification of the selected fragment and the presence of the nonspecific bands that were not eliminated even after the purification stage of the PCR product in the anterior phase of the sequencing stage.
Of the 56 children analyzed, 47 (83.93%) were HIV-1 subtype B infected ( Figure 2 ) and 9 (16.07%) were subtype F1 (Figure 3 ) after consultation were compared in the sequences obtained from www.ncbi.nlm.nih.gov-Retrovirus resource-Genotyping tools-HIV-1. 
Discussion
The study of HIV-1 genetic variations has significant implications for the development of an effective vaccine against the HIV-1 virus. 17, 19 Numerous studies show that multiple HIV-1 subtypes circulate globally where they are often limited by geographical areas or by risk groups; however, the migration of the population has not limited the concentration of several subtypes in certain areas. 7 Perinatal HIV transmission is multifactorial, and all potential risk factors must be considered in the context of the timing of transmission in utero, at birth, or after birth by breastfeeding. Major factors that have been associated with increased transmission include a high maternal virus load, decreased CD4 count, lack of HIV neutralizing antibody, advanced clinical disease, primary infection, first-born twins, and obstetric factors including chorioamnionitis, mode of delivery, and more than 4 hours of ruptured membranes. 20 A study carried out in the UNICAMP, from 1996 to 1998, a prevalence of 29.3% of HIV-1-infected children via perinatal transmission were found. In this study, the prevalence for 13.98%, showing the effectiveness of the medicamentous prophylaxis carried out in the pregnant woman, during the childbirth, at birth, and after the birth. Through the partial sequence analysis of the HIV-1 gene, we can analyze the mutation suffered by the virus in response to the administration of antiretroviral drugs to patients and the predominance of certain strains of HIV with regard to the different forms of the infection on the mother's side, to the corelational analysis between the type of the strain in which the patient is infected and to the fast or slow evolution of the disease. As such, it was possible to identify the predominant subtype of these pediatric population followed at the Hospital das Clínicas da UNICAMP through this study.
In the current study, the presence of the B and F1 HIV-1 subtypes of the patients examined were observed, however, the B subtype was more prevalent (83.93%) compared to the F1 subtype (16.07%).
The geographic distribution of the different subtypes of HIV is not homogeneous and different regions present distinct profiles of prevalence. HIV-1 subtype C is the subtype of higher occurrence worldwide and is the main isolated subtype in some countries of the Middle East, Asia, and Eastern and Southern Africa (http://www.hiv.lanl.gov/content/ index). These are extremely populous regions and present high indices of HIV prevalence. In South America, the main circulating subtype is B; however, subtypes C and F also are epidemiologically important, especially because of the increasing prevalence of subtype C in Brazil. The increase of the prevalence of subtype C in South America stirs up concern, a time that after its entrance in some countries it finished taking advantage on excessively. 14, [21] [22] [23] Previous works had indicated strong evidences of the monophyletic origin of subtype C in Brazil. [24] [25] [26] Similarly, the relationship of the prevalence of subtype B has already been described in several studies, not only in Brazil, but also in Europe and the United States. 27 Brazil is a geographically expansive country and differences in the pattern of subtype distribution have been identified among geographic regions. In a study developed in São Paulo City (Southeast Brazil), subtype B was predominant, with 94% of total cases; subtype F was present in only 6% of total cases. 28 In another more recent study, carried out in Manaus (northern Brazil), similar proportions of B and F subtypes were observed while, in the Southeast, several studies have shown the predominance of subtype B (*85%) followed by subtype F (*10%-15%). 12 Moreover, a clear predominance of subtype B (>80%), with very limited cases of F and C subtypes were, respectively, observed in HIV-1 samples from the Northeast. 29 The presence of subtype C in South Brazil 13 was first detected in 1 of the 5 HIV-1 samples collected in Porto Alegre, Rio Grande do Sul (RS). 12 An increase in the prevalence of subtype C in South Brazil and its occurrence in countries of Latin America have been described. Subtype C is the most prevalent in South Brazil. 14, 30 Several studies on the molecular epidemiology of HIV-1 in Brazil have more recently shown the presence of subtype A. 12 HIV presents extensive genetic variability because of the high error rate of reverse transcriptase. 31, 32 The most widely spread techniques to define HIV subtypes, the HMA, are based on the env gene and are widely used in Brazil as a tool for monitoring subtype distribution. Because intersubtype recombination is an important source of HIV-1 genetic variation, HMA subtyping focusing on 2 distinct HIV regions, env and gag, has been useful 32 ; however, it presents some limitations, one of them is that the primers used can fail, because the virus sequences continue to diverge in several geographic region; as such the HMA primers need to be redesigned in view of the new sequencing data. The patterns must be brought up to date to cover a larger geographic distribution of strains obtained contemporaneously; moreover, this procedure must be characteristic in all technologies to define subtypes. 16 HIV-1 strains can be subtyped indirectly by analysis of the antibody response of the host using synthetic peptides corresponding to the V3 loop of gp120 (V3 serotyping). Serological assays have been shown to be useful tools in some geographical areas. 11 Defining subtypes by the serologic method is also highly dependent on the virus diversity in the population analyzed.
Genome analysis based on DNA sequencing is the most authoratative method for subtyping and is considered the ''gold standard.'' 16 Although this is becoming easier and is now partly automated, it remains time consuming and expensive and requires specific equipment. 11 During the study some difficulties occurred in aquiring appropriate sequencing for posterior viral subtyping in some cases. Among these difficulties were (1) quality problems of the ''Nested-PCR'' of the variable region of the HIV-1 gene for posterior viral sequencing; such problems limited themselves to the presence of nonspecific bands with low intensity, although they remain even after Nested-PCR purification; and (2) low intensity of the amplified bands of nearly 682 bp, where this became less intense after the purification, making difficult the achievement of a quality sequencing satisfactory enough for subsequent analysis and viral genotyping. Because of these difficulties, the HIV-1 subtyping was not possible in 2 of the 58 patients included in the study.
Conclusions
The Nested-PCR for posterior genotyping of HIV-1 was standardized and used in patients being followed at the UNICAMP and showed to be a fast and efficient method, because almost all the samples selected were genotyped properly.
The subtyping of HIV-1 in the samples from HIV-positive children proved a predominance of subtypes B and F1-83.93% (subtype B) and 16.07% (subtype F1)-confirming the predominance of both subtypes in Brazil. These results, however, could be only applicable to the Southeast, and more specifically in the state of Sao Paulo.
